beta-Adrenoceptor blocking agents are important agents in the management of many cardiovascular problems. Multiple neuropsychiatric adverse reactions have been noted with their use. This article reviews these reactions and describes the case of a suspected propranolol-induced psychosis.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10826087909041908DOI Listing

Publication Analysis

Top Keywords

psychosis probable
4
probable result
4
result propranolol
4
propranolol therapy
4
therapy beta-adrenoceptor
4
beta-adrenoceptor blocking
4
blocking agents
4
agents agents
4
agents management
4
management cardiovascular
4

Similar Publications

Background: biomarkers are essential in order to make a diagnosis with a high level of accuracy in patients with cognitive and behavior complaints. However, molecular imaging biomarkers not always provide an answer in daily clinical practice.

Methods: retrospective and descriptive study in patients with Amyloid PET (APscans) implemented according to rational use of this technic, between January 2019-November 2023 in Neurology Department, Infanta Leonor Hospital, Madrid, Spain.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Departments of Psychiatry and Behavioral Sciences, Neurology, and Epidemiology, University of California San Francisco, San Francisco, CA, USA.

Background: Prior studies have found that traumatic brain injury (TBI) is associated with increased risk of both death and dementia in older adults including veterans. Clinically, it would be useful to be able to accurately predict the likelihood of these two outcomes for a given patient.

Method: Our study population included all individuals aged 55 years or older who received care from the Veterans Health Administration between 2002 and 2019, had a TBI diagnosis, had at least one post-TBI healthcare visit, and did not have a dementia diagnosis or medication before or up to 1 month after the TBI (n = 113,779).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.

Background: The APOE ε4 allele (ApoE4) is a known genetic risk factor for developing Alzheimer's disease (AD). Previous work by our group demonstrated that female ApoE4 homozygotes with Lewy body (LB) pathology were significantly more likely to experience psychosis compared to female ApoE4 non-carriers, whereas there was no dose-dependent difference found in males (Valcic et al., 2022).

View Article and Find Full Text PDF

Three-Month Polysubstance Use Patterns Among People Enrolled in Outpatient Treatment for Methamphetamine Use.

Subst Use Misuse

January 2025

National Centre for Youth Substance Use Research (NCYSUR), School of Psychology, The University of Queensland, Brisbane, Australia.

Background: Polysubstance use is common among people who use methamphetamine. This prospective study examined the three-month polysubstance use profiles among people enrolled in outpatient treatment for methamphetamine use and associated substance use, mental health, and treatment correlates.

Method: The present study used routinely collected client-reported outcome measures data from  = 1,507 clients enrolled in outpatient treatment who reported methamphetamine as their primary drug of concern ( = 34.

View Article and Find Full Text PDF

Background: This study evaluated the prevalence of various mental disorders and their influence on mortality outcomes in individuals with cancer.

Methods: The authors' institutional database included patients with cancer diagnosed between 2011 and 2015 who had mental disorders and death information up to 2021. Mental disorders included nonaffective psychotic disorders, affective psychotic disorders, anxiety-related and stress-related disorders, alcohol or drug misuse, and mood disorders without psychotic symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!